FDA approves Sandoz drug for fungal infections
PRINCETON, N.J. — The Food and Drug Administration has approved a drug made by Sandoz for treating yeast and other fungal infections.
Sandoz announced Monday the approval of voriconazole tablets in the 50-mg and 200-mg strengths, a generic version of Pfizer’s Vfend.
Branded and generic versions of the drug had sales of about $189 million during the 12-month period ended in October, according to IMS Health.
US Bioservices receives Specialty Pharmacy Accreditation
VALLEY FORGE, Pa. — US Bioservices, the specialty pharmacy of AmerisourceBergen, on Monday announced that it had received the Specialty Pharmacy Accreditation from URAC, a Washington-based healthcare accrediting organization that establishes quality standards for the healthcare industry.
“US Bioservices’ specialty pharmacy services is focused on helping to positively impact patients’ lives through clinically focused, patient-centric disease and therapy management programs,” stated Craig Miller, US Bioservices’ president. “Our URAC accreditation is a validation of our commitment to quality and accountability in patient care.”
As an independent specialty pharmacy licensed in all states, US Bioservices administers specialty medications, educates patients and provides clinical support to help increase patient compliance to prescribed treatments.
FDA approves Mylan hypertension drug
SILVER SPRING, Md. — The Food and Drug Administration has approved a drug for treating high blood pressure made by Mylan, FDA records showed.
The FDA approved Mylan’s metoprolol succinate tablets in the 25-mg, 50-mg, 100-mg and 200-mg strengths.
The drug is a generic version of AstraZeneca’s Toprol-XL.